Medtronic, Johnson & Johnson MedTech and Siemens Healthineers again lead the Medtech Big 100 list of largest medical device companies. However, there is so much more to Medical Design & Outsourcing and MassDevice‘s 2023 edition of the Medtech Big 100 report. We pulled thousands of data points to provide information on annual revenue, R&D spending, […]
Baxter
The biggest medtech personnel moves so far in 2023
Nearly a quarter of the way through 2023, we’ve seen plenty of movement in the personnel department across medtech. Last July, we broke down the biggest personnel moves in medtech so far in 2022. That was followed up by the full-year report in December. Through more than eight months, the changes atop medtech companies continue […]
Baxter warns on some infusion pumps due to potential false alarms
Baxter (NYSE:BAX) issued an urgent medical device correction for some Spectrum V8 and Spectrum IV infusion pumps in the U.S. The FDA later issued a notice identifying the recall as Class I, the most serious kind. Baxter recalled 22,769 devices in total. Affected pumps in the U.S. and Puerto Rico received upgrades to software versions […]
Baxter stock dips on Q2 results, BPS divestiture uncertainty
Baxter shares fell this morning on second-quarter results that came in mixed compared to the consensus forecast. Shares of BAX fell 4.1% to $46.92 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The Deerfield, Illinois-based company recorded losses of $141 […]
Baxter names proposed kidney care spinoff ‘Vantive’
Baxter announced today that it picked “Vantive” as the name of its proposed kidney care spinoff. In January, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded company. It said at the time that it expected the company to stand alone in the next 12 to 18 […]
Baxter launches PerClot absorbable hemostatic powder
Baxter announced today that it launched the PerClot absorbable hemostatic powder in the U.S. PerClot, a passive, absorbable hemostatic powder, received FDA approval in May. Artivion developed the powder and transferred full ownership to Baxter as part of a sale agreement struck in July 2021. Artivion designed PerClot to control mild bleeding in specific surgical […]
Baxter launches next-gen ICU bed
Baxter announced today that it launched its new intensive care unit bed in the U.S. The Hillrom Progressa+ bed offers new technology and features that make it easier for nurses to care for patients while supporting recovery. Deerfield, Illinois-based Baxter acquired Hillrom and offerings like the Progressa+ ICU bed for $12.5 billion in December 2021. […]
Layoffs in medtech: These companies recently reduced their workforce
The workforce reduction trend has swept the economy recently, and unfortunately, the medtech space is not immune to layoffs. You’ve probably read about the ongoing layoffs sweeping the tech industry, media and more. For instance, Yahoo, Disney, Zoom and more all reported workforce reductions as companies across industries grapple with economic pressures. Think inflation, supply […]
A veteran Medtronic executive takes a new role at Baxter
Medtronic Cardiovascular Diagnostics and Services President Julie Brewer has left for a new position at Baxter. Brewer announced on LinkedIn near the end of last week that she has joined Baxter as President of the Patient Support Systems, Global Surgical Solutions and Care Communications team. “Baxter is a great company with a wonderful purpose of […]
Artivion gains FDA approval for PerClot, starts transfer to Baxter
Artivion today announced FDA premarket application (PMA) approval of its PerClot absorbable hemostatic system designed to control bleeding in specific surgical procedures. The Atlanta-based company will transfer full ownership to Baxter , following a sale agreement that occurred in July 2021. Artivion anticipates receiving an $18.75 million milestone payment under the terms of the agreement. […]
Baxter CFO leaves for same role at GE HealthCare
Baxter announced today that Chief Financial Officer Jay Saccaro will depart for the same role at GE HealthCare . Saccaro leaves Baxter at the end of May after 21 years at the company, including the past eight as CFO. He takes up the title of SVP and CFO and GE HealthCare, effective June 1, 2023. […]
